Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C
- 31 July 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 33 (1) , 135-141
- https://doi.org/10.1016/s0168-8278(00)80170-1
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Ribavirin polarizes human T cell responses towards a Type 1 cytokine profileJournal of Hepatology, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virusPublished by Elsevier ,1998
- Hepatitis C virus infection: virus/host interactionsJournal of Viral Hepatitis, 1998
- Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trialHepatology, 1998
- Tenoxicam, a non-steroid anti-inflammatory drug, is unable to increase the response rate in patients with chronic hepatitis C treated by alpha interferonHepatology, 1998
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Therapy of hepatitis C: OverviewHepatology, 1997
- Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trialHepatology, 1997
- Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis CGastroenterology, 1994